Skip to main content
. Author manuscript; available in PMC: 2011 Nov 14.
Published in final edited form as: J Investig Med. 2010 Dec;58(8):950–956. doi: 10.231/JIM.0b013e3181ff46a5

TABLE 3.

Medication Regimen at Screening and Randomization

Screening Randomization
Antihypertensive Medication, n (%)
 ACEi 68 (84.0) 81 (100)
 Diuretic 53 (65.4) 73 (90.1)
 β-Blocker 33 (40.7) 58 (71.6)
 α-Blocker 3 (3.7) 24 (29.6)
 Central adrenergic agonist 3 (3.7) 8 (9.9)
 Vasodilator 1 (1.2) 1 (1.2)
 ARB 15 (18.5)
 CCB 5 (6.2)
 Spironolactone 1 (1.2)
No. Concomitant non-ACEi
 Antihypertensive Medications, n (%)
 0 20 (24.7) 7 (8.6)
 1 23 (28.4) 15 (18.5)
 2 26 (32.1) 31 (38.3)
 3 10 (12.4) 25 (30.9)
 ≥4 2 (2.5) 3 (3.7)